Last reviewed · How we verify
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
This is a multicenter, open-label Phase 1b study in pediatric patients age 2-11 years old with extensive atopic dermatitis.
Details
| Lead sponsor | Dermavant Sciences GmbH |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 24 |
| Start date | Mon Feb 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Atopic Dermatitis
Interventions
- RVT-501 0.5% topical ointment
Countries
United States